ChinaAMC Hang Seng Hong Kong Biotech Index ETF
18 MAR 2021
China Asset Management (Hong Kong) Limited (“ChinaAMC (HK)”) is a wholly-owned subsidiary of China Asset Management Co. Limited that was incorporated in Hong Kong in September 2008. ChinaAMC (HK) is one of the first mainland Chinese fund management companies licensed to conduct asset management business in Hong Kong and one of the first RQFII fund managers. ChinaAMC (HK) is committed to developing offshore and cross-border asset management businesses in Hong Kong. Its vision is to become a pillar of the international financial architecture, helping to bridge the markets between China and the rest of the world.
ChinaAMC (HK) has developed a broad range of product lines, including long-only funds, hedge funds, Exchange Traded Funds (ETFs), leveraged/Inverse products, bond funds, segregated accounts as well as investment advisory services in order to provide various products and services for both individual and institutional investors in Hong Kong, Greater China Region, Asia Pacific Region, Europe and the U.S.